| Expression pattern: |
UP |
| Associated gene: |
- |
| Associated microRNA: |
- |
| Biological function: |
Biomarker associated with stroke severity, TOAST subtypes, and prognosis (dynamic changes predict unfavorable outcome). |
| Molecular mechanism: |
Not established; authors speculate possible release into circulation after blood-brain barrier disruption and potential link to immune-inflammation. |
| Biological pathway or process: |
not specified |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Clinical Sample Validation; Cohort Study; ROC Analysis; Bioinformatics Analysis |
| Clinical significance: |
Increased plasma circPTP4A2 is associated with AIS severity and stroke subtypes; changes within 7 days predict unfavorable 90-day outcome. |
| Description: |
Plasma circPTP4A2 is up-regulated in AIS patients and higher levels are associated with greater stroke severity (NIHSS) and certain TOAST subtypes (notably LAA). Baseline levels are not predictive of outcome, but the 7-day change in circPTP4A2 helps predict unfavorable 90-day functional outcome. |
| Confidence score: |
0.5121 |